S
Serina Therapeutics Inc (SER)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
$1.36
-0.05 (-3.87%)
Market Cap: $37.73M
Last updated: Nov 17, 2026 at 4:10 PM ET
Serina Therapeutics Inc (SER) Valuation Multiples
Serina Therapeutics (SER) trades at 277.5x sales and 2.5x book value. Its P/S ranged from 147.2x in 2025 to 621.5x in 2024 across the 3 year ends with a P/S figure.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 277.5x |
| Price to book | 2.5x |
| PEG | N/A |
| FCF yield | -65.8% |
Valuation History
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $1.91 | 147.2x | N/A |
| 2024 | $5.01 | 621.5x | 84.0x |
| 2023 | $13.75 | N/A | N/A |
| 2022 | $19.71 | N/A | N/A |
| 2021 | $38.93 | N/A | N/A |
| 2020 | $54.29 | N/A | N/A |
| 2019 | $65.00 | 191.7x | 563.9x |
| 2018 | $106.79 | N/A | N/A |
Frequently Asked Questions About SER
What is SER's price to sales ratio?
Serina Therapeutics has a price to sales ratio of 277.5x.
SER pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors